- Home
- SGHT vs FRST Comparison
SGHT vs FRST Comparison
Compare SGHT & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- FRST
- Stock Information
- Founded
- SGHT 2011
- FRST 2004
- Country
- SGHT United States
- FRST United States
- Employees
- SGHT N/A
- FRST N/A
- Industry
- SGHT Medical Specialities
- FRST Major Banks
- Sector
- SGHT Health Care
- FRST Finance
- Exchange
- SGHT Nasdaq
- FRST Nasdaq
- Market Cap
- SGHT 193.2M
- FRST 273.3M
- IPO Year
- SGHT 2021
- FRST 2006
- Fundamental
- Price
- SGHT $3.52
- FRST $10.99
- Analyst Decision
- SGHT Buy
- FRST Buy
- Analyst Count
- SGHT 8
- FRST 1
- Target Price
- SGHT $4.29
- FRST $420.00
- AVG Volume (30 Days)
- SGHT 109.7K
- FRST 56.5K
- Earning Date
- SGHT 11-06-2025
- FRST 10-23-2025
- Dividend Yield
- SGHT N/A
- FRST 3.63%
- EPS Growth
- SGHT N/A
- FRST N/A
- EPS
- SGHT N/A
- FRST 0.11
- Revenue
- SGHT $76,303,000.00
- FRST $127,561,000.00
- Revenue This Year
- SGHT N/A
- FRST $13.42
- Revenue Next Year
- SGHT $12.04
- FRST $13.48
- P/E Ratio
- SGHT N/A
- FRST $99.33
- Revenue Growth
- SGHT N/A
- FRST 19.27
- 52 Week Low
- SGHT $2.03
- FRST $7.59
- 52 Week High
- SGHT $7.03
- FRST $12.95
- Technical
- Relative Strength Index (RSI)
- SGHT 39.73
- FRST 46.10
- Support Level
- SGHT $3.38
- FRST $10.91
- Resistance Level
- SGHT $3.65
- FRST $11.24
- Average True Range (ATR)
- SGHT 0.16
- FRST 0.22
- MACD
- SGHT -0.07
- FRST -0.03
- Stochastic Oscillator
- SGHT 16.57
- FRST 20.31
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.